國家衛生研究院 NHRI:Item 3990099045/16150
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 906016      在线人数 : 632
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版
    國家衛生研究院 NHRI > 癌症研究所 > 張光裕 > 圖書 >  Item 3990099045/16150


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/16150


    题名: Hypoxia in drug resistance and radioresistance
    作者: Chang, KY;Lin, IL;Cheung, CHA
    贡献者: National Institute of Cancer Research
    摘要: Tumors mostly experience hypoxia or hypoxic stress as they progress, especially for tumor cells that are located far from the functional blood vessels. Pathologically. tumor hypoxia is known to play an important role in tumor progression, and it also contributes to the development of chemoresistance and radioresistance. Among different intracellular signaling pathways, the hypoxia-inducible factor-1 (HIF-1) signaling pathway is the most studied and known for its importance in regulating the survival of cells, including cancer cells, under hypoxic conditions. In the following sections, the molecular biology of hypoxia and the HIF-1 signaling pathway will be briefly reintroduced. Importantly, the role of hypoxia in tumor chemoresistance and radioresistance will be discussed in detail.
    日期: 2023-04-14
    關聯: Hypoxia in Cancer: Significance and Impact on Cancer Therapy. 2023 Apr 14:433-447.
    Link to: http://dx.doi.org/10.1007/978-981-99-0313-9_19
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85202273655
    显示于类别:[張光裕] 圖書

    文件中的档案:

    没有与此文件相关的档案.



    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈